Your browser doesn't support javascript.
loading
Aripiprazole-induced transient myopia: A rare entity
Indian J Ophthalmol ; 2018 Jan; 66(1): 130-131
Article | IMSEAR | ID: sea-196553
Aripiprazole is a new drug for the treatment of adults with schizophrenia. Ocular side effects of aripiprazole are very rare. Review of literature revealed few cases of aripiprazole-induced myopia. We report a rare case of aripiprazole-induced transient myopia. A 22-year-old female patient presented to the department of psychiatry with worsening of symptoms of schizophrenia and was started on aripiprazole. She presented with complaints of blurring of vision in both eyes for 1 week which started on the 3rd day following the use of aripiprazole. Anterior segment examination revealed a shallow anterior chamber and narrow angles. Intraocular pressure was normal. A diagnosis of aripiprazole-induced acute myopia was made and the treating psychiatrist was advised to stop the medication. At 2-week follow-up, the unaided visual acuity improved to 20/20 in both the eyes. Ophthalmologists should be aware of the myopic shift that may occur as an ocular side effect with aripiprazole.
Mots clés
Texte intégral: 1 Indice: IMSEAR Texte intégral: Indian J Ophthalmol Année: 2018 Type: Article
Texte intégral: 1 Indice: IMSEAR Texte intégral: Indian J Ophthalmol Année: 2018 Type: Article